Neurelis Funding & Investors
Neurelis Inc., is a pharmaceutical company. The Company develops and commercializes product candidates for the treatment of central nervous system disorders, acute epilepsy, and anxiety episodes.
neurelis.comTotal Amount Raised: $206,081,952
Neurelis Funding Rounds
Series D
$114,000,000
Series D Investors
HBM Healthcare InvestmentsCormorant Asset ManagementDecheng CapitalLYZZ CapitalPhilos & PartnersSeries Unknown
$40,500,000
Debt Financing
$5,200,000
Series B
$42,098,000
Series B Investors
HBM Healthcare InvestmentsLYZZ CapitalSeries Unknown
$1,500,000
Debt Financing
$1,083,950
Debt Financing
$1,700,000
Funding info provided by Diffbot.